Bleeding Disorders Testing Market Size to Surpass USD 161.9 Million by 2030, at a CAGR of 7.9%

As per the report by Fortune Business Insights, The Bleeding Disorders Testing Market size is projected to reach USD 161.9 Million by 2030, at a CAGR of 7.9% during the forecast period.

Bleeding Disorders Testing Market

Pune, India, Oct. 18, 2023 (GLOBE NEWSWIRE) — The global bleeding disorders testing market size was valued at USD 88.5 million in 2022, and it is set to expand from USD 94.9 million in 2023 to USD 161.9 million by 2030, exhibiting a CAGR of 7.9% over the estimated period. The market growth is being driven by the surging prevalence of bleeding disorders such as Von Willebrand disease, haemophilia A, haemophilia B, and others.

This information is provided by Fortune Business Insights™ in its research report, titled “Bleeding Disorders Testing Market, 2023-2030”.

Key Industry Development:

May 2022 – Precision BioLogic Incorporated rolled out its new solution dubbed CRYOcheck Chromogenic Factor IX assay in Canada, Australia, New Zealand, the U.K., and the European Union.

Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/bleeding-disorder-testing-market-106908

Key Takeaways:

Discover the Leading Players Featured in the Report:

F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthcare GmbH (Germany), HORIBA Ltd. (Japan), Sysmex Corporation (Japan), Abbott (U.S.), Thermo Fisher Scientific Inc. (U.S.), Atlas Medical GmbH (Germany), HYPHEN BioMed (France), Precision Biologics (U.S.)   

Report Scope

Browse Complete Report Details: https://www.fortunebusinessinsights.com/bleeding-disorder-testing-market-106908

Drivers and Restraints:

Market Value to Rise on Account of Growing Prevalence and Diagnosis of Bleeding Disorders

The bleeding disorders testing market growth can be attributed to the escalating prevalence of various disorders in emerging and developed regions. These include idiopathic thrombocytopenic purpura, hemophilia A, hemophilia B, and others.

However, the market growth could be hindered by the low penetration of testing in emerging countries and low adherence to guidelines.

Segments:

Reagents & Consumables Segment Dominated Due to Rising Rate of Testing

Based on product type, the market for bleeding disorders testing is fragmented into instruments and reagents & consumables. The reagents & consumables segment dominated owing to the soaring rate of testing driven by healthcare access in emerging regions.

Hemophilia A Segment Share Dominated Owing to Growing Disease Prevalence

On the basis of indication, the market for bleeding disorders testing is segmented into hemophilia A, idiopathic thrombocytopenic purpura, Von Willebrand disease, hemophilia B, and others. The hemophilia A segment dominated the market due to an upsurge credited to the surging prevalence of bleeding disorders.

Hospitals & Clinics Segment Dominated the Market in 2022 Due to Surge in  Disease Awareness

Based on end-user, the market for bleeding disorders testing is subdivided into diagnostic centers, hospitals & clinics, and others. The hospitals & clinics segment held a leading market share in 2022. This is due to the soaring awareness regarding bleeding disorders among the population.

Citing the regional landscape, the market is classified into Europe, North America, Asia Pacific, and the rest of the world.

By Product Type

• Reagents & Consumables
• Instruments

By Indication

• Hemophilia A
• Hemophilia B
• Von Willebrand Disease
• Idiopathic Thrombocytopenic Purpura
• Others

By End-user

• Hospitals & Clinics
• Diagnostic Centers
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacifi
• Rest of the World

Quick Buy – Bleeding Disorder Testing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/106908

Report Coverage:

The report provides an overview of the significant factors that are expected to impel the business landscape across various regions. It further gives an insight into the major steps taken by leading industry participants for propelling the business scenario throughout the forecast period. These insights have been provided after extensive research and data collation from credible sources.       

Regional Insights:

Europe Dominated the Market Owing to an Upsurge in Patient Population

The Europe bleeding disorders testing market share held a dominant position in the global market. This is mainly impelled by the growing prevalence of disorders in Germany, the U.K., and other countries. Additional factors favoring industry expansion comprise the escalating adherence to guidelines and the growing patient population.

The North America market for bleeding disorders testing is estimated to register appreciable expansion over the forecast period. The rise can be credited to the growing launch of testing instruments and the escalating number of regulatory approvals.

Competitive Landscape:

Market Players to Adopt Strategic Steps to Maintain Industry Position

Leading bleeding disorders testing companies are focused on the adoption of strategic initiatives including the formation of alliances, acquisitions, mergers, and others. These steps are being deployed for the consolidation of their market positions. Some of the additional initiatives include collaborations, partnerships, and the launch of new products.

FAQ’s

How big is the Bleeding Disorder Testing Market?

Bleeding Disorder Testing Market size was USD 94.9 Million in 2023.

How fast is the Bleeding Disorder Testing Market growing?

The Bleeding Disorder Testing Market will exhibit a CAGR of 7.9% during the forecast period, 2023-2030

Related Reports:

Immunodiagnostics Market Share, Size, Trends and Forecast 2023-2030

Hematology Analyzers and Reagents Market Size, Share| Global Forecast Report 2029

Hematology Diagnostics Market Trends, Growth | Global Forecast Report 2030

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India. 

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Attachment

• Bleeding Disorders Testing Market